FDA Calls For More Review Of Aortic Valve Reduced Leaflet Motion
This article was originally published in The Gray Sheet
The agency issued a notification that recent advanced imaging studies have shown reduced leaflet motion in bioprosthetic aortic valves. While FDA believes the devices are reasonably safe and effective, it is working with cardiology societies to design new clinical studies to explore the phenomenon.
Register for our free email digests: